about
Is there a way out for the 2014 Ebola outbreak in Western Africa?BNP and Heart Failure: Preclinical and Clinical Trial Data.Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase.FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.Life-threatening hyponatraemia.Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue.Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling.A review of thiazide-induced hyponatraemia.HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL.Sphingosine-1-phosphate signalling as a therapeutic target for patients with abnormal glucose metabolism and ischaemic heart disease.Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.Mechanisms of renal hyporesponsiveness to BNP in heart failure.Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry.B-type natriuretic peptide and heart failure: what can we learn from clinical trials?Global Longitudinal Strain and Strain Rate in Type Two Diabetes Patients with Chronic Heart Failure: Relevance to Osteoprotegerin.Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes.Letter from Egom regarding article, "High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy".Dynamic changes of the composition of plasma HDL particles in patients with cardiac disease: Spotlight on sphingosine-1-phosphate/serum amyloid A ratio.A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure.Time to redefine body mass index categories in chronic diseases? Spotlight on obesity paradox.Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C.Altered parasympathetic nervous system regulation of the sinoatrial node in Akita diabetic mice.Biochemistry of StatinsHDL-C/HDL-P Ratio: A Measure of Reverse Cholesterol Transport Rather Than HDL FunctionalityA novel method for left anterior coronary artery flow velocity assessment by transthoracic echocardiography at the peak of a supine bicycle testRole of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertensionPulmonary Arterial Hypertension Due to NPR-C Mutation: A Novel Paradigm for Normal and Pathologic Remodeling?
P50
Q26777575-01F7E0B6-C572-456F-BEE4-6BC7D3544DD7Q30909922-28713D63-503D-4DA8-9948-3A57EB472D2BQ33784439-D42D9C1E-4F08-4B70-8B91-DE7B586D9377Q34613106-0B6DF724-B0DD-471A-9EC7-DD540A4775BAQ34990632-F203903A-E526-4033-9DFA-9F6B41A08EBEQ35395763-0D0DCD57-A53E-4016-99E6-5D53099F2CABQ35879566-3EDDFB75-B788-4C8B-AB6A-7F214C2DE3A9Q37220195-37C16CCC-BDA6-44C5-B128-DE22F6B54900Q37950383-2A6BE395-7A02-4544-82BD-032F94D192E8Q38104944-0291F350-24D1-4E07-9FFB-3244AD602429Q38120489-6AE29E80-3C84-4659-8BE0-8D2A526E806FQ38124049-7BE550CA-9623-4403-9464-648135206732Q38424318-F2C6EA5F-4685-4BCA-93DF-FBB05B2017D2Q38640376-71AC6DE6-8311-4AFD-8B9E-0EFD4D7B3BDBQ39007435-C98DD6BA-DCC9-48C2-864C-FB751A36BB2DQ39271023-AACA046F-8B23-4F2B-8730-1056B448381DQ42495601-AB7B2289-6640-44A0-BCBA-BCE194E8FC49Q47174536-1E1FA48E-E89C-40D8-8501-95B8C429DA11Q47430766-7F7D47E8-9C2E-4262-ACA2-E96D8FBD5C73Q47571944-05DBFE85-78E7-470B-A330-2D35AEDF658FQ48139457-C2DECF5A-F002-4568-AC4D-08D982EB712DQ53622545-D8D54B1B-06B9-4D7B-A1CD-814BC9575487Q54285634-0A21B72A-28BD-4833-93AF-8975F4E377D2Q57139238-43174376-6157-493B-BE04-43CDB2A54C3BQ85357992-F8EA1AB0-4503-4882-94AA-95EC040BB1B3Q86925696-692C6034-4AF6-44E7-A8C3-820ECF380FFDQ90284787-9CE0C0B1-4857-4D0B-B250-80DCCCF76C94Q92991075-6F4AD695-EC49-4CD4-BCB5-19E976D3E4C8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emmanuel Egom
@ast
Emmanuel Egom
@en
Emmanuel Egom
@es
Emmanuel Egom
@nl
Emmanuel Egom
@sl
type
label
Emmanuel Egom
@ast
Emmanuel Egom
@en
Emmanuel Egom
@es
Emmanuel Egom
@nl
Emmanuel Egom
@sl
altLabel
Emmanuel Egom
@en
Emmanuel Eroume A Egom
@en
Emmanuel Eroume-A Egom
@en
prefLabel
Emmanuel Egom
@ast
Emmanuel Egom
@en
Emmanuel Egom
@es
Emmanuel Egom
@nl
Emmanuel Egom
@sl
P1053
B-5414-2016
P106
P1153
35366320700
P21
P31
P3829
P496
0000-0001-7142-5477